{"id":49799,"date":"2022-10-19T14:03:25","date_gmt":"2022-10-19T12:03:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/"},"modified":"2022-10-19T14:03:25","modified_gmt":"2022-10-19T12:03:25","slug":"longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/","title":{"rendered":"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022"},"content":{"rendered":"
\n

BETHESDA, Md. & GAITHERSBURG, Md.–(BUSINESS WIRE)–Longhorn Vaccines and Diagnostics LLC<\/a>, a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced that it will present two abstracts at Infectious Disease (ID) Week, being in Washington, DC, Oct. 19 \u2013 23, 2022.\n<\/p>\n

<\/a><\/p>\n

\nThe abstracts focus on Longhorn\u2019s work in developing vaccines for a universal influenza vaccine, antimicrobial resistant bacteria, and the company\u2019s work in COVID-19.\n<\/p>\n

\nAbstract #1
\n
<\/span>Abstract Title:<\/b> IgM Monoclonal Antibodies Targeting Peptidoglycan May Provide Therapeutic Strategies against Antimicrobial Resistant Bacteria
\n
Presenter: <\/b>Clara J. Sei, <\/b>Director, Microbiology and Immunology at Longhorn Vaccines and Diagnostics
\n
Session Title: <\/b>Antimicrobial Novel Agents
\n
Session Date:<\/b> Saturday October 22, 2022
\n
Session Time:<\/b> 12:15 PM – 1:30 PM
\n
Session Location:<\/b> Walter E. Washington Convention Center in Exhibit Hall BC\n<\/p>\n

\nAbstract #2
\n
<\/span>Abstract Title:<\/b> A Composite Peptide Vaccine Comprised of Conserved SARS-CoV-2 and Influenza Epitopes Generated Antisera Reponses to Both Coronavirus and Influenza
\n
Presenter: <\/b>Nimisha Rikhi, Research Scientist at Longhorn Vaccines and Diagnostics
\n
Session Title: <\/b>Updates on Adult Immunizations
\n
Session Date:<\/b> Saturday October 22, 2022
\n
Session Time:<\/b> 1:45 PM – 3:00 PM
\n
Session Location:<\/b> Walter E. Washington Convention Center in room 144 ABC\n<\/p>\n

\nPosters will be available to view on the conference platform during the conference. Further information about IDWeek 2022 can be found here<\/a>.\n<\/p>\n

\nAbout Longhorn Vaccines and Diagnostics LLC<\/b>\n<\/p>\n

\nLonghorn Vaccines and Diagnostics LLC<\/a> is a One Health and One World company based in Maryland that is developing vaccines and diagnostic tools for worldwide public health concerns and to prevent future pandemics. Since its inception in 2006, Longhorn has focused on developing vaccines and diagnostic tools that can impact a pandemic on a global scale and at all socio-economic levels. Since pandemics flow between humans and animals, Longhorn caters to both in order to surveil, diagnose, prevent and treat the next infectious disease.\n<\/p>\n

\nLonghorn\u2019s core product, PrimeStore\u00ae<\/sup> Molecular Transport Medium (MTM), is a patented, FDA cleared, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations, and drug manufacturers improve the diagnosis and treatment of highly infectious diseases such as Influenza, SARS-CoV-2, and Mycobacterium tuberculosis (TB). Unlike standard devices for collecting and transporting virus samples, PrimeStore\u00ae<\/sup> MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nLonghorn Vaccines and Diagnostics LLC
\n
Jeffrey Fischer
\n
Email: jeff@lhnvd.com<\/a>\n<\/p>\n

\nMedia
\n
Alexis Feinberg \u2013 ICR Westwicke PR
\n
Email: LonghornPR@icrinc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BETHESDA, Md. & GAITHERSBURG, Md.–(BUSINESS WIRE)–Longhorn Vaccines and Diagnostics LLC, a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced that it will present two abstracts at Infectious Disease (ID) Week, being in Washington, DC, Oct. 19 \u2013 23, 2022. The abstracts focus on … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49799","6":"format-standard","7":"category-industry"},"yoast_head":"\nLonghorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BETHESDA, Md. & GAITHERSBURG, Md.–(BUSINESS WIRE)–Longhorn Vaccines and Diagnostics LLC, a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced that it will present two abstracts at Infectious Disease (ID) Week, being in Washington, DC, Oct. 19 \u2013 23, 2022. The abstracts focus on ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-19T12:03:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221019005120\/en\/1605791\/21\/Longhorn_Logo_%231.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022\",\"datePublished\":\"2022-10-19T12:03:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/\"},\"wordCount\":421,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005120\\\/en\\\/1605791\\\/21\\\/Longhorn_Logo_%231.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/\",\"name\":\"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005120\\\/en\\\/1605791\\\/21\\\/Longhorn_Logo_%231.jpg\",\"datePublished\":\"2022-10-19T12:03:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005120\\\/en\\\/1605791\\\/21\\\/Longhorn_Logo_%231.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005120\\\/en\\\/1605791\\\/21\\\/Longhorn_Logo_%231.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/","og_locale":"en_US","og_type":"article","og_title":"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022 - Pharma Trend","og_description":"BETHESDA, Md. & GAITHERSBURG, Md.–(BUSINESS WIRE)–Longhorn Vaccines and Diagnostics LLC, a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced that it will present two abstracts at Infectious Disease (ID) Week, being in Washington, DC, Oct. 19 \u2013 23, 2022. The abstracts focus on ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-19T12:03:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221019005120\/en\/1605791\/21\/Longhorn_Logo_%231.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022","datePublished":"2022-10-19T12:03:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/"},"wordCount":421,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221019005120\/en\/1605791\/21\/Longhorn_Logo_%231.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/","url":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/","name":"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221019005120\/en\/1605791\/21\/Longhorn_Logo_%231.jpg","datePublished":"2022-10-19T12:03:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221019005120\/en\/1605791\/21\/Longhorn_Logo_%231.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221019005120\/en\/1605791\/21\/Longhorn_Logo_%231.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/longhorn-vaccines-and-diagnostics-to-present-at-infectious-disease-week-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49799"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49799\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}